Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve

Roger G Clerc1, Andrea Stauffer, Franziska Weibel

  • 1F Hoffmann-La Roche Ltd, Basel, Switzerland.

Abstract

Insights

Cholesteryl ester transfer protein inhibitor torcetrapib increases aldosterone and blood pressure through L-type calcium channels. Unlike other CETP inhibitors, torcetrapib uniquely affects aldosterone production and causes hypertension.

Area of Science:

  • Endocrinology
  • Cardiovascular Pharmacology
  • Molecular Biology

Background:

  • Cholesteryl ester transfer protein (CETP) inhibitors have shown increased mortality.
  • Torcetrapib, a CETP inhibitor, is associated with increased aldosterone production and blood pressure.
  • The mechanisms behind torcetrapib's side effects require investigation.

Purpose of the Study:

  • To investigate the mechanisms underlying torcetrapib-induced aldosterone production and hypertension.
  • To compare the effects of torcetrapib with angiotensin II and a structurally different CETP inhibitor, dalcetrapib.

Main Methods:

  • Aldosterone synthase (CYP11B2) mRNA profiling in H295R cells.
  • Aldosterone production, cytosolic calcium, and ERK phosphorylation assays.
  • RNA interference and genome-wide gene expression screening.
  • Telemetry in spontaneously hypertensive rats.

Main Results:

  • Torcetrapib and angiotensin II increased CYP11B2 mRNA and aldosterone production in H295R cells.
  • Torcetrapib induced a sustained increase in CYP11B2 mRNA, unlike angiotensin II.
  • Torcetrapib's steroidogenic effects were blocked by L-type calcium channel antagonists, unlike angiotensin II.
  • Torcetrapib upregulated L-type calcium channel alpha 1C subunit mRNA and caused hypertension in rats.

Conclusions:

  • Torcetrapib's unique steroidogenic and hypertensive effects are linked to voltage-gated L-type calcium channels.
  • These side effects are not shared by structurally unrelated CETP inhibitors like dalcetrapib.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...